Sahir Ali
General Partner at Modi Ventures
Sahir Ali
General Partner at Modi Ventures
Sugar Land, Texas
Overview
Work Experience
Founder & General Partner
2022 - Current
Investing in fund managers and founders building companies shaping the future of humanity.
Investing into the Next Frontier
Managing Principal
2019
Executive at AIS Modi Capital, Modi family office investing in real estate, manufacturing, and technology.
Investor
2023
Atomic AI is a developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.
Raised $42,000,000.00 from Modi Ventures, Nat Friedman, Neal Khosla, Patrick David Hsu, Doug Mohr, Greylock, Factory, Not Boring, AME Cloud Ventures and Playground Global.
Limited Partner
2023
Draper Associates is an early-stage venture capital firm that invests in industry-transforming companies.
Member, Board of Directors
2023
Advisory Board
2022 - 2023
Investor
2023
Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.
Raised $98,000,000.00 from Modi Ventures, Plum Alley, Tribe Capital, Huadong Medicine and Natural Capital Investment Fund.
Director
2021 - 2021
Leading global initiatives in building system of intelligence for enterprise businesses.
Chief Technology Officer
2018 - 2019
Responsible for taking distributed ledger (Hedera Hashgraph) based medical credentialing app to market.
Intiva Health is the first Hashgraph DLT-based credentialing platform made exclusively for today’s healthcare professionals.
Raised $9,100,000.00.
Enterprise Salesforce Architect
2015 - 2018
Atrium Ingersoll Rand Cognosante Rasmussen College Bazaarvoice
Computational Cancer Scientist
2012 - 2017
- Responsible for development of novel computer vision algorithms for characterizing histopathology specimen on digitized slides. - R&D of a novel image analytics tool by leveraging newly developed vision tools in conjunction with machine learning to predict disease outcome. - Published work as first-authored conference/journal paper in the areas of: Breast Cancer, Oropharyngeal cancer and Prostate Cancer.